Evidence map›Paper›PMID 36097634›Full record

ArticleJournal of translational autoimmunity2022

Compound loss of GSDMD and GSDME function is necessary to achieve maximal therapeutic effect in colitis.

Jianqiu Xiao, Kai Sun, Chun Wang, Yousef Abu-Amer, Gabriel Mbalaviele

Open access · goldAbstract read
In one paragraph

Article in Journal of translational autoimmunity, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 17 citations in OpenAlex.

  1. The gasdermin family: from pyroptosis mechanisms to therapeutic targets.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Berberine AlleviatesInternational journal of molecular sciences · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. Single-Cell Genetic Mapping of Gasdermin Expression Across Immune-Mediated Inflammatory Diseases.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2026
    Article
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Gasdermin D: A New Inflammatory Biomarker in Assessing Clinical Disease Activity in Crohn's Disease.The Turkish journal of gastroenterology : the official journal of Turkish Society of Gastroenterology · 2025
    Article
  14. The gasdermin family: emerging therapeutic targets in diseases.Signal transduction and targeted therapy · 2024
    Review
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jianqiu XiaoDivision of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Kai SunDivision of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Chun WangDivision of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Yousef Abu-AmerDepartment of Orthopaedic Surgery, Washington University School of Medicine, St. Louis, Missouri, USA.
Gabriel MbalavieleDivision of Bone and Mineral Diseases, Washington University School of Medicine, St. Louis, MO, 63110, USA.
Washington University in St. Louis · US

Funding

Resource Based Center for Musculoskeletal Biology and Medicine (Overall Application)P30AR074992 · NIAMS · WASHINGTON UNIVERSITY · PI MATTHEW J SILVA · 2019 to 2026
$6.8M
Regulatory Mechanisms of Implant-Induced OsteolysisR01AR049192 · NIAMS · WASHINGTON UNIVERSITY · PI ABU-AMER, YOUSEF · 2004 to 2019
$4.3M
Differential Inflammasome Regulation in the pathogenesis of S. aureus osteomyelitisR01AI161022 · NIAID · WASHINGTON UNIVERSITY · PI CASSAT, JAMES E, MBALAVIELE, GABRIEL · 2021 to 2025
$3.4M
Role of gasdermin D in bone resorptionR01AR076758 · NIAMS · WASHINGTON UNIVERSITY · PI MBALAVIELE, GABRIEL · 2020 to 2024
$1.9M
Mechanisms of Physiologic and Pathologic OsteoclastogenesisR01AR072623 · NIAMS · WASHINGTON UNIVERSITY · PI ABU-AMER, YOUSEF · 2018 to 2022
$1.7M
NIAID NIH HHS R01 AI161022NIAMS NIH HHS P30 AR074992NIAMS NIH HHS R01 AR049192NIAMS NIH HHS R01 AR072623NIAMS NIH HHS R01 AR076758
6 · The paper itself

Abstract

Gasdermin D (GSDMD) and gasdermin E (GSDME) perpetuate inflammation by mediating the release of cytokines such as interleukin-1β (IL-1β) and IL-18. However, not only are the actions of GSDMD in colitis still controversial, but its interplay with GSDME in the pathogenesis of this disease has not been investigated. We sought to fill these knowledge gaps using the dextran sodium sulfate (DSS) experimental mouse colitis model. DSS ingestion by wild-type mice caused body weight loss as the result of severe gut inflammation, outcomes that were significantly attenuated in

Indexed as

AIM2,, absent in melanoma 2ASC,, apoptosis-associated speck-like protein containing a CARDCD,, Crohn diseasecGAS,, cyclic guanosine monophosphate-adenosine monophosphate (GMP-AMP) synthaseColitisCuET,, bis(diethyldithiocarbamate)-copperDisulfiramDSSDSS,, dextran sodium sulfateGREM1,, gremlin 1GSDMDGSDMD,, gasdermin DGSDMEGSDME,, gasderminEIBD,, inflammatory bowel diseaseIL-1R1,, IL-1 receptor 1IL-1β,, interleukin-1βInflammationNLRC4,, NLR family, CARD domain containing 4NLRP3,, NLR family, pyrin domain containing 3RSPO3,, R-spondin 3TNBS,, 2,4,6-trinitro-benzene sulfonic acidUC,, ulcerative colitis

Identifiers

PMID36097634
PMCPMC9463374
OpenAlexW4293729391

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.